Engflag

Stimuno

Quick links to important sections

Stimuno

Stimuno_DE

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stimuno

Quick Facts

Property Description
Active Ingredient Phyllanthus niruri L. (Standardized Extract)
Form Oral (Syrup, Capsules)
Pharmacological Class Immunomodulator (Immunostimulant)
Common Use Supporting the immune system
Origin Herbal / Natural (Phytopharmaceutical)

What Type of Medicine is Stimuno and What is it Made Of?

Stimuno is a scientifically backed herbal medicinal product classified as an immunomodulator. It is designed to support and strengthen the body's natural defense system, helping to maintain overall health and vitality. This classification means its safety and efficacy have been confirmed through clinical studies, leading to its medical recognition in its country of origin.

The product's sole active ingredient is the standardized extract of Phyllanthus niruri L., an herb widely known in traditional medicine as Meniran. This extract acts as an immunomodulator, working to influence and optimize the immune response. Research has noted that preparations from Phyllanthus niruri L. demonstrate immune-stimulating activity through the activation of key immune components.

Available Forms and General Purpose

Stimuno is a flagship product developed by the Dexa Group (PT Ferron Par Pharmaceuticals). It is available for oral administration in two main forms: a liquid syrup and a solid capsule. Both forms contain the same standardized active ingredient, providing flexibility for users.

A key differentiating factor is its positioning as a Phytopharmaceutical—a standard that requires greater clinical evidence than standard herbal remedies. The general purpose of Stimuno is to assist the body's defenses during times when the immune system needs reinforcement, such as seasonal changes or stress. The therapeutic goal of such agents is to strengthen the body's protective mechanisms against infections.

What side effects are possible with Stimuno?

Possible Side Effects and Safety Information

The regulatory safety profile for Stimuno, which contains the standardized extract of Phyllanthus niruri L., is primarily characterized by adverse events that are mild and non-serious in nature. Official clinical data reviewed by regulatory agencies often reports that the incidence of side effects is comparable to that of a placebo.

Documented Adverse Reactions by System

Adverse reactions that have been reported and documented in official product information fall across several physiological domains. These include: Headache (Nervous System Disorders), Fatigue and Cold (General Disorders), Loss of Appetite (Gastrointestinal Disorders), and changes in urinary function such as Hyperurinaria or Diuresis (Renal and Urinary Disorders). Effects on blood pressure, specifically Hypotension (Vascular Disorders), have also been cited.

Importantly, regulatory documentation notes that no serious adverse events were reported in key clinical studies. The documented mild adverse effects were also found to be resolvable upon completion of the study period.

Population-Specific and Use Restrictions

The product's use is subject to specific regulatory safety constraints, particularly concerning vulnerable populations. Stimuno is Not Recommended during Pregnancy, as pre-clinical data suggests a potential risk to the fetus at high doses. The safety of using the product while Lactating or Breastfeeding has not been established.

Furthermore, official warnings state that the safety of the product has not been established for concurrent use with alcohol or while operating heavy machinery. Consistent with general safety principles, discontinuation is advised if allergy occurs.

Overdose and Emergency Response

The official regulatory profile for overdose of the standardized Phyllanthus niruri L. extract in Stimuno focuses on the potential for an exaggeration of the active ingredient’s known pharmacological effects. Documented presentations of overdose or high-dose exposure may include gastrointestinal discomfort, such as abdominal pain or stomach upset.

More significant manifestations involve the potential for hypoglycemia (excessive blood sugar lowering) and effects on blood coagulation, which may result in slowed blood clotting. Consequently, individuals with diabetes and patients with pre-existing blood clotting disorders are specific populations identified as being at an elevated risk for severe outcomes, which may manifest as an uncontrolled worsening of their chronic condition.

In the event of a suspected overdose, the primary procedural response required by regulatory guidance is to seek immediate medical attention. Urgent medical consultation is mandated if any severe or unexpected symptoms occur, or if a pre-existing medical condition begins to deteriorate. Management of overdose is officially described as consisting of symptomatic and supportive treatment, as no specific pharmacological antidote is known or listed in the official documentation for this standardized herbal extract.

Therapeutic Uses of Stimuno

What Stimuno Treats: Main Uses and Benefits

Stimuno is commonly used as adjunctive therapy—meaning it provides support alongside primary medical treatment—for conditions characterized by periods of heightened symptoms. This approach may include infectious challenges like Chronic Hepatitis B infection or Pulmonary Tuberculosis. This active ingredient is recognized as an herbal immunostimulant with relevance for managing infectious diseases. The product’s application is also relevant for conditions associated with acute or disruptive episodes, such as Upper Respiratory Tract Infections (URTI), Varicella-Zoster infection, and Vaginal Candidiasis.

“The goal of this supportive therapy is to assist with maintaining functional stability during symptomatic phases.”

In real-world scenarios, this Phytopharmaceutical is applied across domains where additional symptomatic support is needed for common acute episodes, like colds and flu. It helps address symptom clusters that may become intense or disruptive. For individuals prone to frequent illness or those experiencing stress, its use may be part of symptomatic management in situations involving recurrent or episodic manifestations. Generally, it provides support that helps ease the overall symptom burden and supports general well-being during symptomatic phases.

Quick Fact: Support for Symptom Management
Primary Context: Adjunctive support for Infectious diseases
Symptom Focus: Helps address symptoms related to systemic imbalance
Benefit: Provides supportive relief

Eligibility and Restrictions for Use

Eligibility for Stimuno: Official Regulatory Information

This section outlines the officially documented rules for who can and cannot use Stimuno, based strictly on governmental regulatory documents.

Contraindicated Populations (Must Not Use)

The medicine is contraindicated for patients with a known history of autoimmune disease or established hypersensitivity to the active ingredient, the standardized Phyllanthus niruri L. extract.

Category Regulatory Status
Autoimmune Disease Contraindicated
Hypersensitivity Contraindicated

Age and Reproductive Status Eligibility

Regulatory documents define specific rules regarding age and physiological states:

  • Age-Group Eligibility: Use is restricted to children older than 1 year and adults (typically 12 years and above). The medicine is not approved for use in infants under 1 year of age.
  • Pregnancy and Lactation: Use during pregnancy is Not Recommended. For breastfeeding women, the regulatory statement is that safety for use during lactation has not been established, setting a clear limitation on eligibility in this group.

No specific restrictions regarding hepatic (liver) or renal (kidney) impairment are explicitly documented within the contraindications section of the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documentation for this standardized Phyllanthus niruri L. extract primarily details interactions based on its classification as an immunostimulant.

Pharmacodynamic Interaction Patterns

The most prominent interaction patterns are defined by the product's functional effect on the immune system, leading to two high-level classifications:

  • Antagonistic Interaction: Co-administration with immunosuppressant agents is noted as having a potential antagonistic functional effect. Medicines such as corticosteroids are specifically mentioned as the immunostimulant activity of Phyllanthus niruri L. may functionally counteract the immunosuppressive action of these drugs.

  • Synergistic Interaction: A potential synergistic functional effect is documented when the product is co-administered with antimicrobial medications. This classification suggests a supportive combined effect that may contribute to the overall therapy.

Other Interaction Considerations

The official interaction profile notes that no data is currently available regarding the product's specific pharmacokinetic interaction (such as CYP-mediated or transporter-based effects) with other medicines. Additionally, regulatory warnings advise that the safety of co-use with alcohol has not been established and requires consultation with a healthcare professional.

No formal prohibitions or explicit timing-based separation rules are documented for co-administration with other medicines, food, or supplements.

Mechanism of Action

Stimuno functions as an immunomodulator, targeting components of both the innate and adaptive immune systems. Its active principles interact with macrophages, dendritic cells (DCs), and lymphocytes including T and B cells.

At the cellular level, the mechanism involves the modulation of key intracellular signaling pathways, such as NF-kappaB, MAPK, and JAK/STAT. This interaction modifies cellular processes, leading to the activation of macrophages and DCs, resulting in an enhancement of their phagocytic activity and antigen-presentation capabilities.

Downstream, the signaling cascades stimulate the transcription and secretion of specific cytokines including Interleukin-1beta (IL-1beta), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-alpha), and Interferon-gamma (IFN-gamma). Concurrently, there is an influence on lymphocyte proliferation and differentiation, which promotes either T-helper type 1 (Th1) or T-helper type 2 (Th2) responses, thus supporting both cellular and humoral immunity.

The system-level physiological consequence is a generalized modulation of the immune response, characterized by enhanced leukocyte functionality and balanced cytokine production.

Dosage and Administration Information

How Stimuno is Used

Stimuno, an immunomodulator containing the standardized extract of Phyllanthus niruri L., is indicated for oral administration across all formulations, including liquid syrup and solid capsules. Usage patterns follow a standardized, non-acute treatment course.

Official Administration Guidelines

Administration is based on a divided dose regimen, which specifies intake three times daily (TID) to ensure consistent exposure to the active ingredient. Dosage amounts are determined by the age group:

Population Dosing Regimen (Three Times Daily)
Pediatric (1–12 Years) 5 mL of syrup per dose
Adults (12 Years and Above) 10 mL of syrup per dose or 1 capsule per dose

Context and Duration of Use

Usage instructions often specify that the medicine should be taken after a meal. The product is intended for outpatient use and does not typically require specialized medical supervision during administration.

For proper use, it is noted that the medicine must be taken regularly for a month or longer to achieve its supportive effects. This minimum duration of use establishes the medicine as a sustained therapy rather than a short-term intervention.

Recent Clinical Evidence

Research evidence / Overview of Studies for Stimuno

Evidence for Use as Adjunctive Support in Chronic Hepatitis B

Research has examined the use of the standardized extract in conditions characterized by fluctuating or episodic manifestations, such as Chronic Hepatitis B infection. Studies explored how the extract was evaluated in a supportive context alongside established treatments or compared to a placebo. Research examined outcomes monitoring specific biomarkers related to the disease, including viral markers and liver enzyme levels. Findings describe patterns observed in the studies where measurements of viral load and liver enzyme levels were monitored over defined time intervals. Evidence is limited regarding the consistent patterns of change across all trials.

Evidence for Use in Acute Viral Challenges (e.g., Varicella-Zoster)

The active ingredient was evaluated in short-term, randomized controlled studies for its role in conditions associated with acute or disruptive episodes, such as chickenpox (Varicella-Zoster) in pediatric populations. Researchers monitored time-to-event outcomes related to lesion progression, such as the time required for new skin lesions to cease appearing. Studies report how symptoms evolved in the observed populations over the short study period. The follow-up durations were limited, and long-term effects are not fully established beyond the immediate acute phase.

Evidence for General Immunomodulatory Properties

The standardized extract was studied for its classification as an immunomodulator. Research examined specific immune cell activity and immune biomarkers (e.g., T-lymphocytes) in pre-clinical and basic science research. Data show patterns related to the activation and influence of immune cells, contributing to the broader evidence landscape supporting its known properties. The specific clinical relevance of these biomarker shifts remains a subject of ongoing research.

What is Still Uncertain About the Evidence Base

Evidence quality varies across studies due to methodological differences and modest sample sizes in some trials. Long-term effects are not fully established regarding sustained stability over years, and comparative evidence is lacking regarding patterns observed when the extract is studied alongside other supportive agents. The evidence applies only to the populations studied, and subgroup findings are uncertain where dedicated trials have not been conducted.

Frequently Asked Questions (FAQ)

Common questions about Stimuno (FAQ)

Q: Is Stimuno described as an 'immunomodulator' in official sources?

Official regulatory documentation classifies Stimuno's pharmacological class as an Immunomodulator (Immunostimulant). This classification indicates its intended function is to influence and optimize the body's immune response.

Q: Is Stimuno intended for long-term use?

Official guidelines for this medicine specify that it should be taken regularly for a minimum duration of one month to achieve its supportive effects. The conditions establish a minimum duration of use, indicating it is intended as a sustained-use product. However, official regulatory texts do not explicitly define a maximum time limit for use beyond this one-month minimum.

Q: How quickly can a person expect to notice any effects from Stimuno?

According to the official product information, the medicine is intended to be taken regularly for a minimum of a month to help achieve its desired supportive effects. The regulatory documentation does not provide specific information regarding what a person may expect to notice in the initial days or weeks of use.

Q: Is there a risk of interaction if Stimuno is taken with common pain relievers?

Official interaction profiles do not classify common pain relievers under the known functional (pharmacodynamic) interaction patterns, which focus on immunosuppressants and antimicrobials. The regulatory safety documents state that no data is currently available regarding the specific way the body processes (pharmacokinetic interaction) this product when taken with other medicines.

Q: Can Stimuno be taken with antibiotics?

Official documentation notes a potential synergistic functional effect when this product is co-administered with antimicrobial medications, which includes antibiotics. This classification suggests a potential supportive functional effect when co-administered.

Q: Does Stimuno interact with caffeine or alcohol?

Official regulatory warnings advise that the safety of co-use with alcohol has not been established. Separately, the official interaction profiles do not contain any information or warnings regarding interaction with caffeine.

Q: Is it okay to take Stimuno with supplements like Vitamin C?

According to the official product information, there are no formal prohibitions or explicit timing-based separation rules documented regarding the co-administration of this product with supplements or other medicines.

Q: Are there any foods that should be avoided when taking Stimuno?

The official interaction documentation for this product contains no formal prohibitions or specific warnings about avoiding certain foods while taking the medicine. The administration instructions typically suggest intake after a meal.

Q: Can Stimuno be taken if I have a chronic condition?

The medicine is officially contraindicated (must not be used) only for patients with a known history of autoimmune disease or established hypersensitivity to the active ingredient. No specific restrictions regarding the use of this product alongside other common non-autoimmune chronic conditions are documented within the official contraindications section.

Q: Are there official warnings about taking Stimuno with heart medication?

Official documentation details interactions with immunosuppressant agents and antimicrobial medications. Specific information or warnings regarding interactions with heart medication are not provided in the regulatory documentation.

Q: Can Stimuno be used during a regular cold or flu?

While research has examined the active ingredient in some acute viral challenges, the primary usage instructions define the product as a sustained therapy intended for use over a month or longer. The provided regulatory texts do not specify its use for the common cold or flu.

Q: Is Stimuno available in liquid form?

Yes, official product information confirms that Stimuno is available for oral administration in a liquid syrup form. It is also available in a solid capsule form.

Q: What is Stimuno's role in supporting immune health?

Stimuno is classified as an immunomodulator, meaning its general purpose is to influence and optimize the immune response. Its role is described as supporting and strengthening the body's natural defense system during times when reinforcement may be needed.

Q: Why is Stimuno listed under certain use conditions?

The product is classified as a Phytopharmaceutical. This is a specific standard that requires confirmation of its safety and intended effect through clinical studies, distinguishing it from standard traditional herbal remedies and defining its use conditions.

Q: Are there any non-drug interactions listed for Stimuno?

Official regulatory safety information notes that safety has not been established for concurrent use with alcohol. Additionally, official warnings advise caution regarding the safety of using the product while operating heavy machinery.

Q: Is Stimuno intended for prevention or for recovery?

Studies have examined the active ingredient's use in both chronic supportive contexts and in short-term acute episodes. The product's role is described as generally supporting the immune system, without being restricted to a specific phase like prevention or recovery.

Q: Are there specific official descriptions for Stimuno's purpose?

Yes, official documents describe the purpose as supporting and strengthening the body's natural defense system. It is also formally classified in regulatory texts as an Immunomodulator (or Immunostimulant).

Q: How does Stimuno relate to the body's natural defenses?

The medicine is described as influencing specific components of the innate and adaptive immune systems, which are key aspects of the body’s natural defenses. Its mechanism involves the modulation of immune cells like macrophages and lymphocytes, enhancing their function to support the body's protective mechanisms.

Q: What is the difference between the adult and children's formulations (if they exist)?

Stimuno is available in a liquid syrup form that is used for both children and adults, and also in a capsule form for adults. While the forms share the same standardized active ingredient, official administration guidelines specify different dosing amounts and frequencies based on the age group.

Q: Do any official sources mention specific dietary restrictions while using Stimuno?

Official documentation and interaction profiles mention no formal prohibitions or explicit timing-based separation rules regarding food intake. The official instructions typically advise taking the medicine after a meal.

How should Stimuno be stored and disposed of?

The official guidelines for storing and disposing of Stimuno focus on maintaining the stability of the active ingredient and ensuring safety, as mandated by regulatory documents.

Storage Requirements

Condition Regulatory Rule
Temperature Store at a temperature below 30°C.
Environment Store in a dry place.
Protection Protect from direct sunlight to maintain stability.
Child Safety Keep out of the sight and reach of children.

These conditions are essential to prevent degradation of the product. The mandatory temperature maximum and the need for a dry, shaded location define the required storage environment.

Disposal

Unused or expired Stimuno must be disposed of according to local regulations for medicinal products. General regulatory principles advise against disposal by flushing down toilets or drains to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Stimuno found in:

A-Z Index: